Business Wire

Study Finds Significant Reduction in Esophageal Injury Rate When Using ensoETM™ During Cardiac Radiofrequency Ablation Procedures

Study incorporated data from over 25,000 patients across 30 sites and compared proactive esophageal cooling to luminal temperature monitoring during RF ablation of the left atrium. CHICAGO--(BUSINESS ...
Business Wire

Vektor Medical Announces Patient Enrollment in VITAL-EP Study Evaluating vMap-Guided Ablations

SAN DIEGO--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent’s has enrolled the first patient in the ...
MedPage Today

EP Study During TAVR Offers Better Prediction of Late Conduction Disturbances

SAN FRANCISCO -- Better indicators of high-grade atrioventricular (AV) conduction system abnormalities following transcatheter aortic valve replacement (TAVR) could be gleaned from an intraprocedural ...
TCTMD

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

SAN FRANCISCO, CA—Conduction abnormalities like complete heart block (CHB) and left bundle branch block (LBBB) remain common in today’s TAVI patients, with some facing pacemaker implantation or even ...
Seeking Alpha

BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care

Westport, CT, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy ...

Pulse Biosciences, Inc.: Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation

U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility study Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary ...